Published in Naunyn Schmiedebergs Arch Pharmacol on February 25, 2004
Immunological profile of peripheral blood lymphocytes and monocytes/macrophages in Kawasaki disease. Clin Exp Immunol (2005) 1.21
Bench-to-bedside review: Immunoglobulin therapy for sepsis - biological plausibility from a critical care perspective. Crit Care (2012) 1.00
Cysteine, histidine and glycine exhibit anti-inflammatory effects in human coronary arterial endothelial cells. Clin Exp Immunol (2012) 0.83
DC-SIGN (CD209) promoter -336 A/G (rs4804803) polymorphism associated with susceptibility of Kawasaki disease. ScientificWorldJournal (2012) 0.82
Amino acids exhibit anti-inflammatory effects in human monocytic leukemia cell line, THP-1 cells. Inflamm Res (2011) 0.80
Intravenous immunoglobulin preparation attenuates LPS-induced production of pro-inflammatory cytokines in human monocytic cells by modulating TLR4-mediated signaling pathways. Naunyn Schmiedebergs Arch Pharmacol (2012) 0.80
Anti-inflammatory effect of intravenous immunoglobulin in comparison with dexamethasone in vitro: implication for treatment of Kawasaki disease. Naunyn Schmiedebergs Arch Pharmacol (2006) 0.80
Association of selected phenotypic markers of lymphocyte activation and differentiation with perinatal human immunodeficiency virus transmission and infant infection. Clin Diagn Lab Immunol (2005) 0.77
IVIG inhibits TNF-α-induced MMP9 expression and activity in monocytes by suppressing NF-κB and P38 MAPK activation. Int J Clin Exp Pathol (2015) 0.76
Effect of CD16a, the surface receptor of Kupffer cells, on the growth of hepatocellular carcinoma cells. Int J Mol Med (2016) 0.75
MicroRNA-93 may control vascular endothelial growth factor A in circulating peripheral blood mononuclear cells in acute Kawasaki disease. Pediatr Res (2016) 0.75
The NF-kappa B and I kappa B proteins: new discoveries and insights. Annu Rev Immunol (1996) 22.30
Function and activation of NF-kappa B in the immune system. Annu Rev Immunol (1994) 17.04
A new infantile acute febrile mucocutaneous lymph node syndrome (MLNS) prevailing in Japan. Pediatrics (1974) 9.97
Control of I kappa B-alpha proteolysis by site-specific, signal-induced phosphorylation. Science (1995) 8.75
Long-term consequences of Kawasaki disease. A 10- to 21-year follow-up study of 594 patients. Circulation (1996) 7.29
Rapid proteolysis of I kappa B-alpha is necessary for activation of transcription factor NF-kappa B. Nature (1993) 6.75
Activation of interleukin-6 gene expression through the NF-kappa B transcription factor. Mol Cell Biol (1990) 6.57
A single intravenous infusion of gamma globulin as compared with four infusions in the treatment of acute Kawasaki syndrome. N Engl J Med (1991) 5.76
Regulation of tumor necrosis factor alpha transcription in macrophages: involvement of four kappa B-like motifs and of constitutive and inducible forms of NF-kappa B. Mol Cell Biol (1990) 5.08
Anti-inflammatory activity of IVIG mediated through the inhibitory Fc receptor. Science (2001) 4.62
Double-stranded RNA-dependent protein kinase activates transcription factor NF-kappa B by phosphorylating I kappa B. Proc Natl Acad Sci U S A (1994) 4.53
The treatment of Kawasaki syndrome with intravenous gamma globulin. N Engl J Med (1986) 4.49
Transcription factors NF-IL6 and NF-kappa B synergistically activate transcription of the inflammatory cytokines, interleukin 6 and interleukin 8. Proc Natl Acad Sci U S A (1993) 4.23
High-dose intravenous gammaglobulin for Kawasaki disease. Lancet (1984) 3.10
Characterization of a functional NF-kappa B site in the human interleukin 1 beta promoter: evidence for a positive autoregulatory loop. Mol Cell Biol (1993) 2.90
Endothelial cell activation and high interleukin-1 secretion in the pathogenesis of acute Kawasaki disease. Lancet (1989) 2.86
Increased levels of circulating intercellular adhesion molecule 1 in Kawasaki disease. Arthritis Rheum (1992) 2.56
The inducible transcription factor NF-kappa B: structure-function relationship of its protein subunits. Biochem J (1993) 2.49
Synergistic transcriptional activation of the IL-8 gene by NF-kappa B p65 (RelA) and NF-IL-6. J Immunol (1994) 2.22
Pathology of the heart in Kawasaki disease. Pediatrics (1978) 2.10
Transcriptional regulation of the human monocyte chemoattractant protein-1 gene. Cooperation of two NF-kappaB sites and NF-kappaB/Rel subunit specificity. J Biol Chem (1997) 1.85
Selective inhibition of E-selectin, vascular cell adhesion molecule-1, and intercellular adhesion molecule-1 expression by inhibitors of I kappa B-alpha phosphorylation. J Immunol (1995) 1.55
Reversal of lymphocyte activation in vivo in the Kawasaki syndrome by intravenous gammaglobulin. J Clin Invest (1987) 1.45
Serial changes of serum interleukin-6, interleukin-8, and tumor necrosis factor alpha among patients with Kawasaki disease. J Pediatr (1992) 1.40
Peripheral blood monocyte/macrophages and serum tumor necrosis factor in Kawasaki disease. Clin Immunol Immunopathol (1988) 1.35
Regulated expression and inhibitory function of Fcgamma RIIb in human monocytic cells. J Biol Chem (2001) 1.27
Clarithromycin inhibits NF-kappaB activation in human peripheral blood mononuclear cells and pulmonary epithelial cells. Antimicrob Agents Chemother (2001) 1.26
Circulating interleukin-1 beta in patients with Kawasaki disease. N Engl J Med (1988) 1.19
Class II major histocompatibility antigen expression on coronary arterial endothelium in a patient with Kawasaki disease. Hum Pathol (1990) 1.16
Elevated circulating tumor necrosis factor-alpha in patients with Kawasaki disease. J Lab Clin Med (1989) 1.10
Human intravenous immunoglobulin modulates monokine production in vitro. Immunology (1990) 1.02
NF-kappaB activation in peripheral blood monocytes/macrophages and T cells during acute Kawasaki disease. Clin Immunol (2001) 0.98
Kawasaki disease differs from anaphylactoid purpura and measles with regard to tumour necrosis factor-alpha and interleukin 6 in serum. Eur J Pediatr (1992) 0.97
In vitro inhibition of tumour necrosis factor-alpha and interleukin-6 production by intravenous immunoglobulins. Br J Haematol (1995) 0.95
Mononuclear cell subsets and coronary artery lesions in Kawasaki disease. Arch Dis Child (1992) 0.94
CD14+CD16+ monocyte subpopulation in Kawasaki disease. Clin Exp Immunol (2000) 0.94
Intravenous immune globulin affects cytokine production in T lymphocytes and monocytes/macrophages. Clin Exp Immunol (1996) 0.92
Spontaneous tumor necrosis factor production in Kawasaki disease. J Pediatr (1989) 0.92
Serum levels of p60 soluble tumor necrosis factor receptor during acute Kawasaki disease. J Pediatr (1994) 0.92
An immunoglobulin agent (IVIG) inhibits NF-kappaB activation in cultured endothelial cells of coronary arteries in vitro. Inflamm Res (2004) 0.87
An essential role for NF-kappaB in human CD34(+) bone marrow cell survival. Blood (1999) 0.83
Activation of peripheral blood monocytes and macrophages in Kawasaki disease: ultrastructural and immunocytochemical investigation. Pathol Int (1998) 0.83
Maturation of macrophages from peripheral blood monocytes in Kawasaki disease: immunocytochemical and immunoelectron microscopic study. Pathol Int (2001) 0.81
Reduction of peripheral blood macrophages/monocytes in Kawasaki disease by intravenous gammaglobulin. Eur J Pediatr (1990) 0.80
Immunology. Giving inhibitory receptors a boost. Science (2001) 0.75
Recent topics related to nephrogenic systemic fibrosis associated with gadolinium-based contrast agents. Int J Urol (2012) 2.05
A severe case of chronic infantile neurologic, cutaneous, articular syndrome treated with biologic agents. Arthritis Rheum (2006) 1.78
Cerebrospinal fluid and serum levels of cytokines and soluble tumor necrosis factor receptor in influenza virus-associated encephalopathy. Scand J Infect Dis (2003) 1.36
Simple genotype analysis of the Asp299Gly polymorphism of the Toll-like receptor-4 gene that is associated with lipopolysaccharide hyporesponsiveness. J Clin Lab Anal (2002) 1.23
Analysis of cytokine levels and NF-kappaB activation in peripheral blood mononuclear cells in influenza virus-associated encephalopathy. Cytokine (2004) 1.19
Anti-inflammatory effect of 1alpha,25-dihydroxyvitamin D(3) in human coronary arterial endothelial cells: Implication for the treatment of Kawasaki disease. J Steroid Biochem Mol Biol (2008) 1.10
Coronary artery outcomes among children with Kawasaki disease in the United States and Japan. Int J Cardiol (2013) 1.05
A novel -66T/C polymorphism in Fc epsilon RI alpha-chain promoter affecting the transcription activity: possible relationship to allergic diseases. J Immunol (2003) 1.05
Ultrasonographic evaluation of cervical lymph nodes in Kawasaki disease. Pediatrics (2002) 1.00
Value of fusion of PET and MRI in the detection of intra-pelvic recurrence of gynecological tumor: comparison with 18F-FDG contrast-enhanced PET/CT and pelvic MRI. Ann Nucl Med (2013) 0.97
Matrix metalloproteinase haplotypes associated with coronary artery aneurysm formation in patients with Kawasaki disease. J Hum Genet (2010) 0.96
Value of fusion of PET and MRI for staging of endometrial cancer: comparison with ¹⁸F-FDG contrast-enhanced PET/CT and dynamic contrast-enhanced pelvic MRI. Eur J Radiol (2013) 0.96
Serum cytokine concentrations of influenza-associated acute necrotizing encephalopathy. Pediatr Int (2003) 0.94
Genome-wide linkage and association mapping identify susceptibility alleles in ABCC4 for Kawasaki disease. J Med Genet (2011) 0.92
A boy with a severe phenotype of succinic semialdehyde dehydrogenase deficiency. Brain Dev (2011) 0.92
Clinical utility of apparent diffusion coefficient values obtained using high b-value when diagnosing prostate cancer using 3 tesla MRI: comparison between ultra-high b-value (2000 s/mm²) and standard high b-value (1000 s/mm²). J Magn Reson Imaging (2012) 0.91
Regulation of human Fc epsilon RI alpha-chain gene expression by multiple transcription factors. J Immunol (2002) 0.91
Polymorphisms in the Fc epsilon RI beta promoter region affecting transcription activity: a possible promoter-dependent mechanism for association between Fc epsilon RI beta and atopy. J Immunol (2004) 0.91
Effect of montelukast on nuclear factor kappaB activation and proinflammatory molecules. Ann Allergy Asthma Immunol (2005) 0.91
Serum and CSF levels of cytokines in acute encephalopathy following prolonged febrile seizures. Brain Dev (2007) 0.89
Japanese pediatric guideline for the treatment and management of bronchial asthma 2012. Pediatr Int (2014) 0.88
Roles of matrix metalloproteinase-9 and tissue inhibitors of metalloproteinases 1 in acute encephalopathy following prolonged febrile seizures. J Neurol Sci (2007) 0.88
Serum and cerebrospinal fluid levels of cytokines in acute encephalopathy associated with human herpesvirus-6 infection. Brain Dev (2008) 0.88
Congenital cystic adenomatoid malformation complicated by esophageal duplication cyst in a 6-month-old girl. Pediatr Pulmonol (2002) 0.87
Preoperative risk stratification using metabolic parameters of (18)F-FDG PET/CT in patients with endometrial cancer. Eur J Nucl Med Mol Imaging (2015) 0.87
CSF cytokine and chemokine profiles in acute disseminated encephalomyelitis. J Neuroimmunol (2006) 0.87
Different effects of novel mtDNA G3242A and G3244A base changes adjacent to a common A3243G mutation in patients with mitochondrial disorders. Mitochondrion (2009) 0.87
Serum levels of matrix metalloproteinase-9 and its tissue inhibitor (TIMP-1) in acute disseminated encephalomyelitis. J Neuroimmunol (2006) 0.87
MMP-9 and TIMP-1 in the cord blood of premature infants developing BPD. Pediatr Pulmonol (2009) 0.86
Ultrasonographic findings of facial dysmorphism in Wolf-Hirschhorn syndrome. Am J Perinatol (2005) 0.86
Effects of sequential exposure to lipopolysaccharide and heat stress on dental pulp cells. J Cell Biochem (2006) 0.85
Soluble tumor necrosis factor receptor 1 and tissue inhibitor of metalloproteinase-1 in hemolytic uremic syndrome with encephalopathy. J Neuroimmunol (2008) 0.85
Analysis of serum soluble CD40 ligand in patients with influenza virus-associated encephalopathy. J Neurol Sci (2005) 0.84
Cysteinyl leukotrienes induce monocyte chemoattractant protein-1 in human monocyte/macrophages via mitogen-activated protein kinase and nuclear factor-kappaB pathways. Int Arch Allergy Immunol (2009) 0.84
Regulation of the human high affinity IgE receptor beta-chain gene expression via an intronic element. J Immunol (2003) 0.84
Association of CCR2-CCR5 haplotypes and CCL3L1 copy number with Kawasaki Disease, coronary artery lesions, and IVIG responses in Japanese children. PLoS One (2010) 0.84
Cerebrospinal fluid levels of cytokines in non-herpetic acute limbic encephalitis: comparison with herpes simplex encephalitis. Cytokine (2008) 0.83
Staphylococcal enterotoxin-specific IgE antibodies in atopic dermatitis. Pediatr Int (2004) 0.83
[Regulation of proinflammatory cytokine cascade in Kawasaki disease]. Nihon Rinsho (2008) 0.83
Matrix metalloproteinase-9 and tissue inhibitors of metalloproteinases 1 in influenza-associated encephalopathy. Pediatr Infect Dis J (2007) 0.82
Functional expression of cysteinyl leukotriene receptors on human platelets. Platelets (2010) 0.82
Effects of antiasthma drugs on the growth of Chlamydophila pneumoniae in HEp-2 cells. J Infect Chemother (2003) 0.81
Inhibition of shiga toxin cytotoxicity in human renal cortical epithelial cells by nitrobenzylthioinosine. J Infect Dis (2002) 0.81
Japanese pediatric guidelines for the treatment and management of bronchial asthma 2008. Pediatr Int (2009) 0.81
Low-dose non-enhanced CT versus full-dose contrast-enhanced CT in integrated PET/CT scans for diagnosing ovarian cancer recurrence. Eur J Radiol (2012) 0.81
Matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 in perinatal asphyxia. Brain Dev (2008) 0.80
Anti-inflammatory effect of intravenous immunoglobulin in comparison with dexamethasone in vitro: implication for treatment of Kawasaki disease. Naunyn Schmiedebergs Arch Pharmacol (2006) 0.80
The effect of inhaled corticosteroids on Chlamydophila pneumoniae and Mycoplasma pneumoniae infection in children with bronchial asthma. J Infect Chemother (2009) 0.80
Amino acids exhibit anti-inflammatory effects in human monocytic leukemia cell line, THP-1 cells. Inflamm Res (2011) 0.80
Cysteinyl leukotrienes induce macrophage inflammatory protein-1 in human monocytes/macrophages. Int Arch Allergy Immunol (2008) 0.80
Fosfomycin inhibits NF-kappaB activation in U-937 and Jurkat cells. Int J Antimicrob Agents (2003) 0.79
Dexamethasone decreases cerebrospinal fluid soluble tumor necrosis factor receptor 1 levels in bacterial meningitis. Brain Dev (2007) 0.79
Serological identification of endothelial antigens predominantly recognized in Kawasaki disease patients by recombinant expression cloning. Microbiol Immunol (2004) 0.79
Nuclear factor-kappaB activation in peripheral blood mononuclear cells in children with sepsis. Crit Care Med (2007) 0.78
Clinical characteristics of respiratory syncytial virus infection-associated acute otitis media. Pediatr Int (2009) 0.78
Safety from thromboembolism using intravenous immunoglobulin therapy in Kawasaki disease: Study of whole-blood viscosity. Pediatr Int (2003) 0.78
NF-kappaB activation in cerebrospinal fluid cells from patients with meningitis. Neurol Res (2002) 0.78
Ginkgo nut intoxication in a 2-year-old male. Pediatr Neurol (2006) 0.77
Mononuclear cell subpopulations in CSF and blood of children with bacterial meningitis. J Infect (2008) 0.77
Time lag between the increase of IL-6 with fever and NF-kappaB activation in the peripheral blood in inflammatory myofibroblastic tumor. Cytokine (2008) 0.77
Analysis of cytokine levels in cerebrospinal fluid in mumps meningitis: comparison with echovirus type 30 meningitis. Cytokine (2005) 0.77
Serum matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 levels in non-herpetic acute limbic encephalitis. J Neurol (2009) 0.77
Theophylline inhibits NF-kappaB activation in human peripheral blood mononuclear cells. Int Arch Allergy Immunol (2002) 0.77
Prostaglandin E2 suppresses beta1-integrin expression via E-prostanoid receptor in human monocytes/macrophages. Cell Immunol (2010) 0.76
Regulation of human FcepsilonRI beta chain gene expression by Oct-1. Int Immunol (2003) 0.76
Low-dose carbamazepine therapy for benign infantile convulsions. Brain Dev (2005) 0.76
Regulation of the human Fc epsilon RI alpha-chain distal promoter. J Immunol (2003) 0.76
Clinical characteristics of benign convulsions with rotavirus gastroenteritis. J Child Neurol (2009) 0.76